Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium BRICS Research on diabetes drug therapy market provides in-depth analysis of segments and sub-segments in the BRICS as well as regional diabetes drug therapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the BRICS and regional diabetes drug therapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of BRICS diabetes drug therapy market. According to the report, the BRICS diabetes drug therapy market is projected to grow at a healthy CAGR over the forecast period of 2021-2027.
Diabetes is a disease commonly attributed to economic wealth and prosperity. The prevalence of diabetes is increasing in BRICS countries and will inevitably threaten their bristling economies to adequately invest in healthcare infrastructure. Diabetes is the major cause of blindness, kidney failure, heart attack, and stroke. In BRICS countries, the number of people affected by all types of diabetic disorders is now over four times higher than just 40 years ago. This has led the WHO (World Health Organization) to consider diabetes an epidemic, predicting it will soon be the seventh biggest cause of death worldwide.
The factors such as increased foreign direct investment, the arrival of fast-food restaurants, and increasingly sedentary lifestyles, have caused diabetes cases to rapidly increase in countries such as Brazil, India, and China. Approximately 12 million people have diabetes in Brazil, and the current prevalence ranges from 6.3% to 13.5%. China, which is the most populous country as well as ranks number one with an estimate of 109.6 million adults with diabetes. The prevalence of diabetes in China has sharply increased over the past three decades. In India, more than 77 million are living with diabetes which is predicted to increase to 134 million by 2045. Additionally, raising awareness about diabetes drug therapies among patients is anticipated to escalate the growth of the diabetes drug therapy market in the near future. On the other hand, low awareness about diabetes drug therapy countries is expected to hamper the growth of the diabetes drug therapy market. Moreover, ongoing technological advancements and the introduction of advanced insulin delivery devices are projected to create several growth opportunities in the diabetes drug therapy market in the near future. All of the BRICS countries are experiencing a dearth of primary healthcare services due to the spread of COVID-19. There is also a large deficiency of beds, x-ray machines, and other medical devices. The majority of hospitals and clinics are preferring to cure the covid patients which negatively impacts the diabetes drug therapies.
Geographically, China holds the largest market share in the BRICS diabetes drug therapy market as health concerns in China are rising due to the prevalence of various diseases. The diabetes drug therapy market is mainly driven by increasing demand for diabetes drugs from China and India. Presently, China has over 120 million diabetes patients, whereas the number of diabetes patients in India is expected to reach 87 million by 2025.
The report on BRICS diabetes drug therapy market covers segments such as service type, and application. On the basis of service type, the sub-markets include insulin, biguanides, meglitinides, sulfonylureas, inhibitors, and others. On the basis of application, the sub-markets include type 1 diabetes, type 2 diabetes, and gestational diabetes.
The report provides profiles of the companies in the market such as Becton, Dickinson and Company, Roche Diagnostics Ltd, Johnson and Johnson, Bayer AG, Abbott Laboratories, Acon Laboratories, Inc., Ypsomed AG, Novo Nordisk A/S, Medtronic plc, ARKRAY Inc, and Terumo Corporation.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of diabetes drug therapy market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Please Choose One of them.